Related Experiment Video
Updated: Aug 7, 2026
07:47
Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Drug stop: newer beta-lactam antimicrobials
Journal of Neurosurgical Nursing
|June 1, 1985
Summary
Newer beta-lactam antimicrobials provide broader activity and safety. Reserve these advanced antibiotics for specific infections to prevent resistance and manage costs effectively.
Area of Science:
- Pharmacology
- Infectious Diseases
Background:
- Older beta-lactam antimicrobials have limitations in spectrum and efficacy.
- Emerging bacterial resistance necessitates the development of new antimicrobial agents.
Purpose of the Study:
- To evaluate the clinical utility of newer beta-lactam antimicrobials.
- To provide guidance on the appropriate use of advanced beta-lactam agents.
Main Methods:
- Review of existing literature on beta-lactam antimicrobial activity and safety profiles.
- Analysis of clinical scenarios where newer agents demonstrate superior efficacy.
- Assessment of cost-effectiveness and resistance patterns associated with antimicrobial use.
Main Results:
- Newer beta-lactams exhibit an expanded spectrum of activity compared to older agents.
- Agents like cefuroxime and third-generation cephalosporins show promise in treating specific infections such as meningitis.
- Penicillins are effective in combination therapy for Pseudomonas infections.
Conclusions:
- Newer beta-lactam antimicrobials offer significant advantages in treating resistant infections.
- Judicious use of advanced beta-lactams is crucial to preserve their efficacy and control healthcare costs.
- These agents should be reserved for situations where older beta-lactams are insufficient.
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...